» Articles » PMID: 38918821

Diagnosis and Treatment Status of Inoperable Locally Advanced Breast Cancer and the Application Value of Inorganic Nanomaterials

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2024 Jun 25
PMID 38918821
Authors
Affiliations
Soon will be listed here.
Abstract

Locally advanced breast cancer (LABC) is a heterogeneous group of breast cancer that accounts for 10-30% of breast cancer cases. Despite the ongoing development of current treatment methods, LABC remains a severe and complex public health concern around the world, thus prompting the urgent requirement for innovative diagnosis and treatment strategies. The primary treatment challenges are inoperable clinical status and ineffective local control methods. With the rapid advancement of nanotechnology, inorganic nanoparticles (INPs) exhibit a potential application prospect in diagnosing and treating breast cancer. Due to the unique inherent characteristics of INPs, different functions can be performed via appropriate modifications and constructions, thus making them suitable for different imaging technology strategies and treatment schemes. INPs can improve the efficacy of conventional local radiotherapy treatment. In the face of inoperable LABC, INPs have proposed new local therapeutic methods and fostered the evolution of novel strategies such as photothermal and photodynamic therapy, magnetothermal therapy, sonodynamic therapy, and multifunctional inorganic nanoplatform. This article reviews the advances of INPs in local accurate imaging and breast cancer treatment and offers insights to overcome the existing clinical difficulties in LABC management.

Citing Articles

Invasion and metastasis in cancer: molecular insights and therapeutic targets.

Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X Signal Transduct Target Ther. 2025; 10(1):57.

PMID: 39979279 PMC: 11842613. DOI: 10.1038/s41392-025-02148-4.

References
1.
Ramirez-Garcia G, de la Rosa E, Lopez-Luke T, Panikar S, Salas P . Controlling trapping states on selective theranostic core@shell (NaYF:Yb,Tm@TiO-ZrO) nanocomplexes for enhanced NIR-activated photodynamic therapy against breast cancer cells. Dalton Trans. 2019; 48(27):9962-9973. DOI: 10.1039/c9dt00482c. View

2.
Qin L, Jiang S, He H, Ling G, Zhang P . Functional black phosphorus nanosheets for cancer therapy. J Control Release. 2019; 318:50-66. DOI: 10.1016/j.jconrel.2019.12.013. View

3.
Liu Y, Bhattarai P, Dai Z, Chen X . Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev. 2018; 48(7):2053-2108. PMC: 6437026. DOI: 10.1039/c8cs00618k. View

4.
Hu P, Shang L, Chen J, Chen X, Chen C, Hong W . A nanometer-sized protease inhibitor for precise cancer diagnosis and treatment. J Mater Chem B. 2019; 8(3):504-514. DOI: 10.1039/c9tb02081k. View

5.
Cheng C, Chen W, Zhang L, Wu H, Zink J . A Responsive Mesoporous Silica Nanoparticle Platform for Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound-Stimulated Cargo Delivery with Controllable Location, Time, and Dose. J Am Chem Soc. 2019; 141(44):17670-17684. DOI: 10.1021/jacs.9b07591. View